InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Clarke John K, 董事. Insider active across 2 companies, notably aTYR PHARMA INC. In total, 2 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €9k. History available since 21 May 2021. The latest transaction was disclosed on 21 May 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Clarke John K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
6,000 股Common StockSEC:0001209191-23-026069:0
2,500 股@ US$4.34100.0% 占其流量Common StockSEC:0001209191-21-035836:0
2 条申报中的 2 条
About Clarke John K
John K. Clarke is a Board Member at aTYR PHARMA INC. He plays a crucial role in the strategic direction of the company, which focuses on developing treatments for rare diseases. His expertise helps guide key decisions for the company's future.
